Pharmacokinetics of piperaquine after repeated oral administration of the antimalarial combination CV8 in 12 healthy male subjects Daniel RöshammarTrinh Ngoc HaiMichael Ashton Clinical Trials 29 March 2006 Pages: 335 - 341
Reported adverse drug reactions during the use of inhaled steroids in children with asthma in the Netherlands T. W. de VriesJ. J. de Langen-WouterseL. T. W. de Jong-Van den Berg Pharmacodynamics 01 April 2006 Pages: 343 - 346
Inhibitory effects of L- and T-type calcium antagonists on contractions of human detrusor muscle Jasmin Katrin BadawiHeng LiStephan Bross Pharmacodynamics 07 April 2006 Pages: 347 - 354
The influence of various genotypes on the metabolic activity of NAT2 in a Chinese population Bing ChenWei-Xia ZhangWei-Min Cai Pharmacogenetics 29 March 2006 Pages: 355 - 359
Differentiation of innovator versus generic cyclosporine via a drug interaction on sirolimus John M. KovarikAdele NoeRobert L. Schmouder Pharmacokinetics ans Disposition 18 March 2006 Pages: 361 - 366
Pharmacokinetics of dihydroartemisinin following oral artesunate treatment of pregnant women with acute uncomplicated falciparum malaria R. McGreadyK. StepniewskaF. Nosten Pharmacokinetics and Disposition 22 March 2006 Pages: 367 - 371
National campaigns to improve antibiotic use Herman GoossensDidier GuillemotPeter G. Davey Pharmacoepidemiology and Prescription 28 March 2006 Pages: 373 - 379
A small economic inducement to stimulate increased reporting of adverse drug reactions—a way of dealing with an old problem? M. BäckströmT. Mjörndal Pharmacoepidemiology and Prescription 30 March 2006 Pages: 381 - 385
Medicine-related problems resulting in emergency department visits M. Isabel BaenaM. Jose FausAntonio Zarzuelo Pharmacoepidemiological and Prescription 08 April 2006 Pages: 387 - 393
Screening for polymorphisms in the PXR gene in a Dutch population Tessa M. BoschMaarten DeenenIrma Meijerman Short Communication 28 March 2006 Pages: 395 - 399